Zollinger–Ellison syndrome
MeSH: D015043ORPHA: 913
Overview
disease of the digestive tract in which tumors lead to excess acid and peptic ulcers
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with Zollinger–Ellison syndrome, sourced from HPO and Orphanet clinical annotations.
Zollinger-Ellison syndromeNeuroendocrine neoplasmDiarrheaNauseaEpisodic abdominal painDuodenal ulcerPeptic ulcerEsophagitisWeight lossHyperparathyroidismElevated circulating growth hormone concentrationThyroid adenomaJaundiceMultiple lipomasGastrointestinal hemorrhageHematocheziaPituitary adenomaHypercalcemiaIncreased circulating cortisol levelElevated circulating parathyroid hormone levelIntestinal obstructionPituitary prolactin cell adenomaParathyroid hyperplasiaAdrenocortical adenomaPituitary corticotropic cell adenomaErythemaPituitary growth hormone cell adenomaPituitary null cell adenomaIncreased urinary cortisol levelLipomaExtrahepatic cholestasisGlucagonomaIncreased glucagon levelAdrenocortical carcinoma
Classification & Codes
MeSH Code
D015043Orphanet Code
ORPHA:913Zollinger–Ellison syndrome
| MeSH | D015043 |
| Orphanet | ORPHA:913 |
| Treatments | 0 drug(s) |
| Symptoms on record | 34 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO